EUVIMEDOpdag EUVIMED
Crossref

Coptisine inhibits the malignancy of bladder carcinoma cells and regulates XPO1 expression

Jie Li, Xiuheng Liu

Chemical Biology & Drug Design · 2023

DOI: 10.1111/cbdd.14291 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2023. Written by Jie Li and 1 co-authors. Institution: Department of Urology, Renmin Hospital of Wuhan University, Wuhan, China. Major MEDLINE topics: Urinary Bladder Neoplasms, Carcinoma. Cited 4 times so far (Crossref); 38 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

This work is performed to investigate the effect of coptisine (COP) on the malignant biological behaviors of bladder carcinoma cells and its underlying mechanism. Bladder carcinoma cell lines were treated with different concentrations of COP in vitro. Cell counting kit‐8 (CCK‐8), scratch healing assay, Transwell assay, and flow cytometry were used to detect cell growth, migration, invasion, and cell cycle progression. Bioinformatics analysis was performed to predict the molecular targets of COP. Quantitative real‐time PCR and western blot were adopted to determine the expression levels of exportin 1 (XPO1) mRNA and protein, respectively. Gene set enrichment analysis was applied to predict the signaling pathways related to XPO1. This study showed that COP treatment markedly suppressed the malignant biological behaviors of bladder carcinoma cells. XPO1 was identified as a downstream molecular target of COP in bladder carcinoma, and COP treatment inhibited the expression of XPO1 in bladder carcinoma cell lines. Overexpression of XPO1 reversed the impacts of COP on the malignant biological behaviors of bladder carcinoma cells. COP treatment modulated the expression level of cyclin D1 and CYP450 via XPO1. In summary, COP represses the malignant biological behaviors of bladder carcinoma cells and regulates XPO1 expression, which is promising to be a complementary drug for bladder carcinoma treatment.

Subjects

MeSH terms (MEDLINE)

Urinary Bladder NeoplasmsCarcinomaHumansUrinary BladderCell Line, TumorCell ProliferationCell MovementGene Expression Regulation, NeoplasticExportin 1 ProteinBerberine

Author keywords

XPO1bladder carcinomacell cyclecoptisineproliferation

Substances

Exportin 1 ProteincoptisineBerberine

Authors and institutions

  • Department of Urology, Renmin Hospital of Wuhan University, Wuhan, China.

Cite

APA

Li, J., & Liu, X. (2023). Coptisine inhibits the malignancy of bladder carcinoma cells and regulates XPO1 expression. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14291

Vancouver

Li J, Liu X. Coptisine inhibits the malignancy of bladder carcinoma cells and regulates XPO1 expression. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14291

BibTeX
@article{Li2023,
  author = {Li, Jie and Liu, Xiuheng},
  title = {Coptisine inhibits the malignancy of bladder carcinoma cells and regulates XPO1 expression},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  doi = {10.1111/cbdd.14291}
}
Start for free →